📌 Key Takeaways
- Topic: Is Silica in Cosmetics Safe? Ingredient Safety and Regulatory Status
- Keywords: rheology modifier silica
- Published: 2026-11-20 07:31:51
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for Wafer Polishing: Slurry Types, Particle Size and Performance
- Silica Testing Methods: How to Test Purity, Particle Size, BET and Moisture
- What Is Silica Gel? How It Works, Types and Uses as a Desiccant and Adsorbent
- Mesoporous Silica Nanoparticles as Drug Delivery Systems
- Quartz for Engineered Stone: Purity, Whiteness and Safety Requirements
- 55. Antonino R.S., Ruggiero M., Song Z., Nascimento T.L., Lima E.M., Bohr A., Knopp M.M., Löbmann K. Impact of drug loading in mesoporous silica-amorphous formulations on the physical stability of drugs with high recrystallization tendency. Int. J. Pharm. X. 2019;1:100026. doi: 10.1016/j.ijpx.2019.100026. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
- Silica for Powder Coatings: Flow Aid, Matting and Anti-Caking Functions
Silica as a Food Additive: Uses, E551 Approval and Safety
What is silica (SiO₂)?
precipitated silica Mathematical modeling, particularly the application of the Fick diffusion equation, is really beneficial in clarifying and predicting drug release from polymeric or porous matrices. Fick's laws describe diffusion as the movement of molecules from a greatly concentrated region to a region where the concentration is lower. Fick's first law presumes the diffusion flux to be directly proportional to the concentration gradient. Fick's second law controls the spatial and temporal change in concentration in the release medium [ 59 ]. For drug release, the general equation is as follows (Equation (3)).
What is the difference between fumed silica and precipitated silica?
quartz sand price
What drives silica raw material prices?
silica for floor coatings Another study concentrated on repaglinide, an oral antidiabetic drug [ 84 ] from the BCS class II, with poor solubility but high permeability. In addition, it has a significant first-pass effect, and the combination of these two features results in low oral bioavailability. The researchers prepared a repaglinide solid dispersion employing mesoporous silica to enhance solubility and drug release. Based on in vitro tests, the repaglinide-MSN complex exhibited significant improvement, compared to the pure drug [ 84 ]. Then this solid dispersion was effectively incorporated into a medicated chewing gum. This buccal administration causes the drug to bypass first-pass metabolism, further boosting oral bioavailability. Based on their clinical investigations, the researchers proved that this formulation showed an increased antidiabetic activity compared to the marketed product by measuring blood glucose levels. In summary, this solid dispersion chewing gum formulation can be a promising perspective in antidiabetic therapy [ 84 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.